Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FQ83G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,522
Award facts
- Contract value 100% obligated
- $16,522.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Beyfortus 100 mg/ml syringes valued at $16,522.02. This is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-competitive award under the company's existing contract vehicle with DLA. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody indicated for infants and young children, reflecting the federal government's medical procurement needs for specialized immunobiological products.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its established capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FQ83G?
SPE2DB26FQ83G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FQ83G worth?
The government has obligated $16,522 on SPE2DB26FQ83G.
Is contract SPE2DB26FQ83G an order under another contract?
Yes. SPE2DB26FQ83G is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ83G competed?
The extent of competition for SPE2DB26FQ83G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award